Newsletter 16: Announcing new regen technology & chemo screening diagnostics

Lattice Biologics Preparing to Launch Three New Products Featuring Matrix-Assisted Regeneration (MAR) Technology

Issue 16: April 23 2016 – Read the complete newsletter here.

This newsletter includes some very BIG updates, including: the opportunity for select surgeons to receive our experimental precision chemotherapy screening diagnostic service free of charge for their patients; the announcement of three new allograft products expected to launch in the coming quarters that utilize our patent pending matrix-assisted regeneration (MAR) technology; and the opportunity for YOU to take advantage of our brand new private placement raise with ground floor benefits and special warrant perks.

INVESTOR UPDATE:

Newest Lattice Financing: Our Deal Room Site is Now Open!
Lattice Biologics Ltd. is raising USD $300,000. We are utilizing the Stockhouse Deal Room to streamline financing management and paperwork and to facilitate easy access for investors to participate in this private placement.

To get in on the action, check out our Deal Room listing here.

View the Stockhouse DealRoom

LATTICE IN THE NEWS:

Lattice Biologics (TSX-V: LBL) Adds Biotech Opportunity to Stockhouse’s Deal Room
April 22, 2016 – Lattice Biologics extended investment opportunities directly to accredited investors today when the company went live on Stockhouse’s new revolutionary Deal Room, a curated directory of finance offerings being made available through exempt market dealer, Waverley Corporate Financial Services.

PRESS RELEASES:

Lattice Biologics Preparing to Launch Three New Products Featuring Matrix-Assisted Regeneration (MAR) Technology (4/18/16)
Amniotic tissue matrix, demineralized cortical fiber, and viable cell allografts to accelerate company’s top line revenue

Lattice Biologics Offering Exclusive Access to Revolutionary High-Throughput Precision Chemotherapy Screening for Breast Cancer (4/15/16)
Company is developing cutting edge technology to enter the $35B cancer tumor profiling market.

UPCOMING INDUSTRY EVENTS:

The 84th American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
Lattice will be attending the AANS meeting in Chicago, May 2-7, 2016.  If you will be in town, let’s pick a time to meet up!

 

If you enjoy these updates, please share them with your friends and colleagues.  As always, we appreciate your support on this journey!

 

Sincerely,
Guy Cook, CEO
Lattice Biologics Ltd.


 

Read the complete newsletter here.

Click Subscribe to receive updates.

______

Media Contact: Melanie Battista, Public Relations, Lattice Biologics Ltd., 16701 N 90th Street, Suite #101, Scottsdale, AZ 85260, 480-563-0800 Office, News@LatticeBiologics.com | www.LatticeBiologics.com

Subscribe to Lattice News Updates

Follow us on Twitter: @LatticeBio